A comprehensive multidisciplinary thoracic aortic program improves patient quality metrics after type A aortic dissection repair
JTCVS Open · 2026-02 · 29 · 101514
DOI: 10.1016/j.xjon.2025.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift JTCVS Open, 2026-02. Verfasst von Christopher R Burke und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the impact of a multidisciplinary thoracic aortic program on quality care metrics among survivors of type A aortic dissection.
Methods
In 2019 our center implemented a comprehensive multidisciplinary thoracic aortic program (MTAP) comprising aortic-trained cardiac surgeons, vascular surgeons, cardiologists, medical geneticists, and dedicated support personnel. In this study, we compared quality-care metrics for patients who underwent type A aortic dissection repair at a single academic institution in the 5 years before (2014-2018, "pre-MTAP," n = 87) and 4 years after (2019-2022, "MTAP," n = 126) the implementation of our MTAP program.
Results
Process-of-care metrics were defined as postoperative clinical follow-up, aortic imaging surveillance rates, rates of appropriate genetic testing, and planned versus unplanned aortic reintervention. Patients in the MTAP cohort were more likely to undergo genetic testing (34% vs 15%, P = .002), had a greater per-year aortic surveillance imaging rate (1.3 scans vs 0.49 scans, P < .001), and more frequently followed up with a vascular surgeon (62% vs 46%, P = .022) compared with the pre-MTAP group. Additionally, fewer patients in the MTAP group had no follow-up or were lost to follow-up during the study period (25% vs 38%, P = .05). Aortic reinterventions in the MTAP group were more commonly planned at the index Type A dissection operation as part of a multistage procedure (33% vs 11%, P = .040) and were more likely performed endovascularly (91% vs 54%, P = .002). No patients in the MTAP group required emergent reintervention compared to 2 patients (7.1%) in the pre-MTAP group. No between group difference in survival was noted.
Conclusions
Establishment of an MTAP program improved clinical follow-up and diagnostic testing and allowed planned reintervention in survivors of type A aortic dissection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiothoracic Surgery, University of Washington, Seattle, Wash.
- Division of Vascular Surgery, University of Washington, Seattle, Wash.
- Division of Anesthesia, University of Washington, Seattle, Wash.
- Division of Cardiology, University of Washington, Seattle, Wash.
- Division of Medical Genetics, University of Washington, Seattle, Wash.
Zitieren
APA
Burke, C. R., Sweet, M. P., DeGraaff, B., Dhanekula, A., Tugan, D., Flodin, R., Otto, C. M., Buber, J., Byers, P. H., Schwarze, U., Upson, M., Zettervall, S. L., & DeRoo, S. (2026). A comprehensive multidisciplinary thoracic aortic program improves patient quality metrics after type A aortic dissection repair. JTCVS Open, 29, 101514. https://doi.org/10.1016/j.xjon.2025.11.005
Vancouver
Burke CR, Sweet MP, DeGraaff B, Dhanekula A, Tugan D, Flodin R, et al. A comprehensive multidisciplinary thoracic aortic program improves patient quality metrics after type A aortic dissection repair. JTCVS Open. 2026;29:101514. doi:10.1016/j.xjon.2025.11.005
BibTeX
@article{Burke2026,
author = {Burke, Christopher R and Sweet, Matthew P and DeGraaff, Bret and Dhanekula, Arjune and Tugan, Dariga and Flodin, Rachel and Otto, Catherine M and Buber, Jonathan and Byers, Peter H and Schwarze, Ulrike and Upson, Melissa and Zettervall, Sara L and DeRoo, Scott},
title = {A comprehensive multidisciplinary thoracic aortic program improves patient quality metrics after type A aortic dissection repair},
journal = {JTCVS Open},
year = {2026},
volume = {29},
pages = {101514},
doi = {10.1016/j.xjon.2025.11.005}
}
EUVIMED